http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0220053-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D235-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 1986-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1988-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0220053-A3
titleOfInvention Benzimidazoles, benzoxazoles, benzothiazoles and their production, formulation and use as gastric acid secretion inhibitors
abstract There are described compounds of formula I, n nin which A is a benzene or heterocyclic ring, ny is 0 or 1, nL is a group containing 1 or 2 carbon atoms, or is a nsingle bond, nR₉ and R₁₀ have a variety of significances, eg nR₁₀ may form part of a double bond with L, or nthe group -NR₉R₁₀ forms a ring carrying nsubstituents R₁ to R₈, or nwhen L is a single bond -NR₁₀ and R₈ may form a nring carrying substituents R₁₆ to R₂₅, or nthe group -LNR₉R₁₀ forms a heterocyclic ring ncarrying substituents R₂₆ to R₃₃, nR₁ to R₈ and R₁₆ to R₃₃ have a variety of nsignificances nn is 0, 1 or 2, n n nx is 3, 4 or 5, nX is S, O or NR₁₅, nR₁₅ is hydrogen, -COR, -COOR or alkyl optionally nsubstituted by -OCOR, nand certain provisos. n Processes for making the compounds and pharmaceutical nformulations containing them, eg for the treatment of nconditions involving excess gastric acid secretion, are nalso described.
priorityDate 1985-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0130729-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0045200-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409451045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 29.